Emerging concepts: Novel integration of in vivo approaches to localize the function of nicotinic receptors

Journal of Neurochemistry

Volumn 100, Issue 3, 2007, Pages 596-602

  Maskos, Uwe ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Acetylcholine; Behaviour; Electrophysiology; Lentivirus; Nicotine; Nicotinic receptor

Indexed keywords

LENTIVIRUS VECTOR; NICOTINE; NICOTINIC RECEPTOR;

BRAIN FUNCTION; BRAIN REGION; CHOLINERGIC ACTIVITY; GENE EXPRESSION; HUMAN; MICRODIALYSIS; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SHORT SURVEY; TRANSGENE;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DOPAMINE; HUMANS; NEURONS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION; TOBACCO USE DISORDER;

LENTIVIRUS; MUS;

EID: 33846213929     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04224.x     Document Type: Short Survey

References (65)

1. Anglade P., Tsuji S., Hirsch E. C., Javoy-Agid F. and Agid Y. (1993) Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain. Histol. Histopathol. 8, 501-504.
2. Anglade P., Tsuji S., Agid Y. and Hirsch E. C. (1995a) Neuronal plasticity and Parkinson disease. Mol. Chem. Neuropathol. 24, 251-255.
3. Anglade P., Tsuji S., Javoy-Agid F., Agid Y. and Hirsch E. C. (1995b) Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease. Ann. Neurol. 37, 265-272.
4. Avale M., Pons S., Granon S., Faure P., Changeux J. P. and Maskos U. (2006) Targetted lentiviral re-expression of beta2* nicotinic receptors in the nigrostriatal pathway unravels their crucial role in the control of locomotion. Abstract 556.15. Neuroscience Meeting Planner. Society for Neuroscience, Atlanta, GA.
5. Bertrand D. (2002) Neuronal nicotinic acetylcholine receptors and epilepsy. Epilepsy Curr. 2, 191-193.
6. Besson M., David V., Suarez S., Cormier A., Cazala P., Changeux J. P. and Granon S. (2006) Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. Psychopharmacology (Berlin) 187, 189-199.
7. Bierer L. M., Haroutunian V., Gabriel S., Knott P. J., Carlin L. S., Purohit D. P., Perl D. P., Schmeidler J., Kanof P. and Davis K. L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64, 749-760.
8. Carr D. B. and Sesack S. R. (2000) GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38, 114-123.
9. Champtiaux N. and Changeux J. P. (2002) Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 1, 319-330.
10. Champtiaux N. and Changeux J. P. (2004) Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog. Brain Res. 145, 235-251.
11. Changeux J.-P. and Edelstein S. (2005) Acetylcholine Nicotinic Receptors: from Molecular Biology to Cognition. Odile Jacob, Paris.
12. Cordero-Erausquin M., Marubio L. M., Klink R. and Changeux J. P. (2000) Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol. Sci. 21, 211-217.
13. Dajas-Bailador F. and Wonnacott S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 317-324.
14. Dani J. A. (2003) Roles of dopamine signaling in nicotine addiction. Mol. Psychiatry 8, 255-256.
15. Dani J. A. and De Biasi M. (2001) Cellular mechanisms of nicotine addiction. Pharmacol. Biochem. Behav. 70, 439-446.
16. Dani J. A., Ji D. and Zhou F. M. (2001) Synaptic plasticity and nicotine addiction. Neuron 31, 349-352.
17. David V., Besson M., Changeux J. P., Granon S. and Cazala P. (2006) Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50, 1030-1040.
18. David V., Segu L., Buhot M. C., Ichaye M. and Cazala P. (2004) Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin 1B receptors. Psychopharmacology (Berlin) 174, 367-375.
19. Chiara G. and Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274-5278.
20. Drago J., McColl C. D., Horne M. K., Finkelstein D. I. and Ross S. A. (2003) Neuronal nicotinic receptors: insights gained from gene knockout and knockin mutant mice. Cell Mol. Life Sci. 60, 1267-1280.
21. Faure P., Neumeister H., Faber D. and Korn H. (2003) Symbolic analysis of swimming trajectories reveals scale invariance and provides a model for fish locomotion. Fractals 11, 233-243.
22. Fountaine T. M., Wood M. J. and Wade-Martins R. (2005) Delivering RNA interference to the mammalian brain. Curr. Gene Ther. 5, 399-410.
23. Freedman R., Coon H., Myles-Worsley M., et al. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl Acad. Sci. USA 94, 587-592.
24. Girones R., Cote P. J., Hornbuckle W. E., Tennant B. C., Gerin J. L., Purcell R. H. and Miller R. H. (1989) Complete nucleotide sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host. Proc. Natl Acad. Sci. USA 86, 1846-1849.
25. Gotti C. and Clementi F. (2004) Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74, 363-396.
26. Gotti C., Riganti L., Vailati S. and Clementi F. (2006) Brain neuronal nicotinic receptors as new targets for drug discovery. Curr. Pharm. Des. 12, 407-428.
27. Granon S. and Poucet B. (2000) Involvement of the rat prefrontal cortex in cognitive functions: a central role for the prelimbic area. Psychobiology 28, 229-237.
28. Granon S., Save E., Buhot M. C. and Poucet B. (1996) Effortful information processing in a spontaneous spatial situation by rats with medial prefrontal lesions. Behav. Brain Res. 78, 147-154.
29. Granon S., Vidal C., Thinus-Blanc C., Changeux J. P. and Poucet B. (1994) Working memory, response selection, and effortful processing in rats with medial prefrontal lesions. Behav. Neurosci. 108, 883-891.
30. Granon S., Faure P. and Changeux J. P. (2003) Executive and social behaviors under nicotinic receptor regulation. Proc. Natl Acad. Sci. USA 100, 9596-9601.
31. Hogg R. C. and Bertrand D. (2004) Nicotinic acetylcholine receptors as drug targets. Curr. Drug Targets CNS Neurol. Disord. 3, 123-130.
32. Hogg R. C., Raggenbass M. and Bertrand D. (2003) Nicotinic acetylcholine receptors: from structure to brain function. Rev. Physiol. Biochem. Pharmacol. 147, 1-46.
33. King S. L., Marks M. J., Grady S. R., Caldarone B. J., Koren A. O., Mukhin A. G., Collins A. C. and Picciotto M. R. (2003) Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. J. Neurosci. 23, 3837-3843.
34. Laviolette S. R. and van der Kooy D. (2004) The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat. Rev. Neurosci. 5, 55-65.
35. Lena C. and Changeux J. P. (1998) Allosteric nicotinic receptors, human pathologies. J. Physiol. Paris 92, 63-74.
36. Lester H. A., Fonck C., Tapper A. R., McKinney S., Damaj M. I., Balogh S., Owens J., Wehner J. M., Collins A. C. and Labarca C. (2003) Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action. Curr. Opin. Drug Discov. Devel. 6, 633-639.
37. Mameli-Engvall M., Evrard A., Pons S., Maskos U., Svensson T. H., Changeux J.-P. and Faure P. (2006) Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50, 911-921.
38. Mansuy I. M. and Bujard H. (2000) Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol. 10, 593-596.
39. Maskos U., Kissa K., St Cloment C. and Brûlet P. (2002) Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc. Natl Acad. Sci. USA 99, 10 120-10 125.
40. Maskos U., Molles B. E., Pons S., et al. (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436, 103-107.
41. Mesulam M. M., Mufson E. J., Wainer B. H. and Levey A. I. (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10, 1185-1201.
42. Naldini L., Blomer U., Gage F. H., Trono D. and Verma I. M. (1996a) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. USA 93, 11 382-11 388.
43. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M. and Trono D. (1996b) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
44. Parain K., Hapdey C., Rousselet E., Marchand V., Dumery B. and Hirsch E. C. (2003) Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin. Brain Res. 984, 224-232.
45. Perry E. K., Smith C. J., Court J. A. and Perry R. H. (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J. Neural Transm. Park. Dis. Dement. Sect. 2, 149-158.
46. Perry E. K., Morris C. M., Court J. A., Cheng A., Fairbairn A. F., McKeith I. G., Irving D., Brown A. and Perry R. H. (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64, 385-395.
47. Perry E. K., Lee M. L., Martin-Ruiz C. M., et al. (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158, 1058-1066.
48. Picciotto M. R. (1999) Knock-out mouse models used to study neurobiological systems. Crit. Rev. Neurobiol. 13, 103-149.
49. Picciotto M. R. (2003) Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci. 24, 493-499.
50. Picciotto M. R. and Zoli M. (2002) Nicotinic receptors in aging and dementia. J. Neurobiol. 53, 641-655.
51. Picciotto M. R., Zoli M., Rimondini R., Lena C., Marubio L. M., Merlo Pich E., Fuxe K. and Changeux J. P. (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177.
52. Picciotto M. R., Zoli M. and Changeux J. P. (1999) Use of knock-out mice to determine the molecular basis for the actions of nicotine. Nicotine Tob. Res. 1, S121-S125; discussion S139-140.
53. Picciotto M. R., Caldarone B. J., Brunzell D. H., Zachariou V., Stevens T. R. and King S. L. (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol. Ther. 92, 89-108.
54. Quik M. (2004) Smoking, nicotine and Parkinson's disease. Trends Neurosci. 27, 561-568.
55. Renner M. J. (1990) Neglected aspects of exploratory behavior and investigatory behavior. Psychobiology 18, 16-22.
56. Rossi F. M., Pizzorusso T., Porciatti V., Marubio L. M., Maffei L. and Changeux J. P. (2001) Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system. Proc. Natl Acad. Sci. USA 98, 6453-6458.
57. Sauer B. (1998) Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392.
58. Shoaib M., Gommans J., Morley A., Stolerman I. P., Grailhe R. and Changeux J. P. (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42, 530-539.
59. Terzano S., Court J. A., Fornasari D., Griffiths M., Spurden D. P., Lloyd S., Perry R. H., Perry E. K. and Clementi F. (1998) Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Brain Res. Mol. Brain Res. 63, 72-78.
60. Wonnacott S., Sidhpura N. and Balfour D. J. (2005) Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5, 53-59.
61. Yakel J. L. and Shao Z. (2004) Functional and molecular characterization of neuronal nicotinic ACh receptors in rat hippocampal interneurons. Prog. Brain Res. 145, 95-107.
62. Yang D., Niu Y. and He F. (2005) Functional changes of nicotinic acetylcholine receptor in muscle and lymphocyte of myasthenic rats following acute dimethoate poisoning. Toxicology 211, 149-155.
63. Zennou V., Petit C., Guetard D., Nehrbass U., Montagnier L. and Charneau P. (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-185.
64. Zennou V., Serguera C., Sarkis C., Colin P., Perret E., Mallet J. and Charneau P. (2001) The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19, 446-450.
65. Zoli M., Picciotto M. R., Ferrari R., Cocchi D. and Changeux J. P. (1999) Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J. 18, 1235-1244.